Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletine.
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000276:immunology*; D000941:Antigens; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007428:Intradermal Tests; D008012:Lidocaine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology; D008801:Mexiletine / Q000009:adverse effects / Q000276:immunology*; D011437:Propylamines / Q000276:immunology*; D013329:Structure-Activity Relationship; D016677:Tocainide
D000889:Anti-Arrhythmia Agents; D000941:Antigens; D011437:Propylamines; D008801:Mexiletine; D016677:Tocainide; D008012:Lidocaine